Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2014


Hungary Life Sciences, Biotech & Healthcare Investment Conference

22 Jan 2014 - 22 Jan 2014 - Budapest, Hungary



Bookmark and Share


A not-to-be-missed event showcasing Hungary’s achievements as the most innovative pharmaceutical and healthcare hub in CEE and beyond. 

Get the first -hand information from the relevant industry professionals and assess the market potential.

The proposed conference is part of our Healthcare series of events dedicated to the Central European pharmaceutical and medical markets. Following the successful events concluded in Russia, Kazakhstan, Poland, Romania, Georgia, Azerbaijan and Ukraine, it is now Hungary’s turn to be showcased. Hungary’s life sciences and medical technology industry is well-developed and has been granted international recognition. Innovative SMEs are continuously growing in numbers and strength, while foreign med tech producers have indentified Hungary as an attractive investment destination, offering a highly productive workforce. Featuring one of the largest and most developed drug markets in CEE, Hungary ranks n°1 in the region for FDI in the pharmaceutical sector. Investors will find several fast-growing and renowned R&D institutions and the country has the highest number of biotech companies in the region and keeps attracting new ones. Registration process is open for delegates and we currently offer an early bird discount.


Further information
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!